retatrutide approved Promises Big Weight Loss, but Safety Remains a Question The FDA has issued warning
Description
Dias-Junior et al
In patients tolerating empagliflozin, the dose may be increased to 25 mg
If maximum weight loss is the priority and you can tolerate more side effects, retatrutide delivers substantially better results
It is designed as a triple agonist that activates GIP, GLP-1, and glucagon receptors
Hum Reprod Update (2009) 16(3):27692
Now, followers are criticizing her for making what they allege are misleading claims about her own weight loss journey, with some demanding refunds for the course
